News

6 genetic risk factors for Parkinson’s disease have been discovered thanks to a study conducted by an international consortium of researchers, including Professor Alexis Brice’s team at the Brain and Spine Institute – Institut du Cerveau - ICM...

Neuroscience, Ethics and Society (NES) is an initiative of Institut du Cerveau - ICM, for the purpose of integrating ethics and neuroscience through education. Co-Directors of the project are Yves Agid, MD, PhD and Thomasine Kushner, PhD. To...

A research team of the Institut du Cerveau - ICM institute took part to an international study identifying 18 new genes implicated in hereditary spastic paraplegias (HSP). This work, published on January the 31th on the prestigious website of the...

A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the...

The illustration of this article is on the cover of the latest issue of the journal “Brain, a Journal of Neurology”

Hereditary Spastic Paraplegia (HSP) are a genetically heterogeneous group of invalidating neurological disorders characterized by a progressive difficulty walking due to stiff legs (spastic) and additional neurological signs like epilepsy, ataxia...

The aim of Dr A. Sittler, from the Alexis Brice and Giovanni Stevanin team, is to develop a new therapeutic strategy for the spinocerebellar ataxia SCA7.

Henry Raker came to the Institut du Cerveau - ICM today and gave to Pr Gérard Saillant the cheque of the donation made on Ball XX on september 2012. He told us how fantastic was the BB Cycle Challenge, that just ended on 26th of May. We thank all the...

A research team directed by Giovanni Stevanin and Alexis Brice from the Brain and Spine Institute, in collaboration with other teams of the international SPATAX network (coordinator, Alexandra Durr), have identified 3 new causative genes in...

MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has...

One of the most exciting challenges in neurosciences is to understand how the brain encodes and stores new information from the environment in order to produce adequate changes in behaviour. In the past, the prevailing view concerning the cellular...

Paris, on January 21st 2013 A new convention between the Institut du Cerveau - ICM and IPGM (Institution of social welfare member of Groupe KLESIA), was signed in the premises of the Institute, situated in Paris. This signature was made in the...